1. Interleukin (IL)- 6 inhibition - Follow-up data of the German AID-registry1
- Author
-
Gregor Dückers, Elke Lainka, Eggert Lilienthal, Rainer Berendes, Klaus Tenbrock, G. Horneff, Helmut Wittkowski, Prasad T. Oommen, Thomas Lutz, E Husmann, Dirk Föll, M. Bielak, Ulrich Neudorf, N. Weyandt, Jens Klotsche, Elisabeth Weißbarth-Riedel, Georg Heubner, J.-P. Haas, Tim Niehues, and Tilmann Kallinich
- Subjects
medicine.medical_specialty ,Innate immune system ,biology ,business.industry ,Medizin ,Arthritis ,Interleukin ,Bioinformatics ,medicine.disease ,Rheumatology ,Proinflammatory cytokine ,Pathogenesis ,Internal medicine ,Pediatrics, Perinatology and Child Health ,Immunology ,Poster Presentation ,biology.protein ,Etiology ,Immunology and Allergy ,Medicine ,Pediatrics, Perinatology, and Child Health ,ComputingMethodologies_GENERAL ,business ,Interleukin 6 - Abstract
Systemic juvenile idiopathic arthritis (SJIA) is regarded as an autoinflammatory disease (AID) of unknown etiology related to abnormalities of the innate immune system. A major role in the pathogenesis has been ascribed to proinflammatory cytokines as interleukin (IL)-6 and IL-1.
- Published
- 2015